Skip to content

Postural Garment Versus Exercises for Women With Cervical Pain

A Comparative Study of Postural Garment Versus Exercises for Women With Non-specific Cervical Pain: a Randomised Crossover Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03560492
Enrollment
70
Registered
2018-06-18
Start date
2017-04-20
Completion date
2021-01-30
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Pain, Posture

Keywords

posture, cervical pain, exercise

Brief summary

This study aim to compare a new postural garment (Posture Plus Force ®) versus exercises in women with non specific cervical pain. The investigators focus on nurses and allied health professionals due to the importance of posture in work related musculoskeletal disorders.

Detailed description

OBJECTIVE: To investigate the effects of a postural garment versus exercises in nurses with non-specific cervical pain. DESIGN: Randomized cross over clinical trial with a 3 months sequence treatment and a 3 months washout period.. PARTICIPANTS: Nurses and allied health professionals with cervical pain aged 21 to 55 years. INTERVENTIONS: Participants are allocated at random to receive interventions in two groups: * P+ : a postural garment (Posture Plus Force - FGP srl ® - Italy) to be worn from 2 to 4 hours per day, during 90 days. * Ex: five physiotherapy sessions to learn stretching and strengthening exercises (20 minutes) with instructions to continue at home on a daily basis for 90 days. The subjects in each group will be cross over after three months of wash out period. MAIN OUTCOME MEASURES: The primary outcomes are postural control and pain intensity. Pictures on sagittal and frontal plane as well as measurements of static posturography with a scan (SpinalMouse ®) are conducted at T0 (pre-intervention), T1 immediately after garment fitting for P+ group and after the 5th session for Ex group, T30, T60 and T90 at day 30, day 60 and day 90 of follow-up. Pain is measured by visual analogue scale (VAS) on the same assessment days. STATISTICAL ANALYSIS: Statistical analysis is conducted following intention-to-treat principles, and the treatment effects calculated using linear mixed models.

Interventions

OTHERExercises

5 sessions of exercises of 20 minutes each. Participants have to do a set of cervical, dorsal and abdominal stretching and strengthening exercises. Participants receive instructions to continue at home on a daily basis for 3 months and record compliance in a logbook.

DEVICEPosture garment

Participants are provided with the appropriate size of a posture garment which includes thoracic and abdominal tensional bands. They are instructed to wear it 2 to 4 h per day for a 3 month period and record compliance in a logbook daily.

Sponsors

University of Andorra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Postural assessment is performed by a blinded investigator with a device for computerized measurement of surface curvature in the upright position (SpinalMouse®).

Intervention model description

Participants are randomised to receive one intervention during the initial 3 month phase of the study and receive the other intervention during the second 3 month phase of the study, after a wash out 3 month period.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Nurses and health allied professionals females with cervical pain * Voluntarily signed informed consent * Able to wear the garment and to do exercises and follow up assessments

Exclusion criteria

* Pregnancy * Malignancy or other severe disease * Cervical pain with significant extremity symptoms and/or neurological dysfunction (cervical radiculopathy and cervical spondylotic myelopathy) * Unable to perform exercises * Unwilling to do follow up assessments * Psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline cervical Pain measured with a visual analog scale at 3 monthsPain is assessed pre-intervention (Day 0) and at Month 3 of follow-up.Visual analogue scale is a psychometric measuring instrument designed to document cervical pain severity in individual subjects. It achieves a rapid (statistically measurable and reproducible) classification of symptom severity. A 100-mm long horizontal line with verbal descriptors is used to grade the amount of pain that a patient feels from no pain (left 0 mm) to an extreme amount of pain (right 100 mm).
Change from baseline cervical Pain at 3 months (after the wash out period)After the washout period, pain is assessed at baseline (Month 6) and after 3 months of intervention (Month 9)Visual analogue scale is a psychometric measuring instrument designed to document cervical pain severity in individual subjects. It achieves a rapid (statistically measurable and reproducible) classification of symptom severity. A 100-mm long horizontal line with verbal descriptors is used to grade the amount of pain that a patient feels from no pain (left 0 mm) to an extreme amount of pain (right 100 mm).

Secondary

MeasureTime frameDescription
Pain Catastrophizing ScaleAssessed pre-intervention (Day 0)In order to assess the catastrophizing dimension related to pain, the Pain Catastrophizing Scale is used. It is a 13-item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time) that yields a total score and three subscale scores assessing rumination, magnification and helplessness. Total score ranges from 0 to 52. It is a self-report measurement tool that provided a valid index of catastrophizing in clinical populations.
Neck Disability IndexNeck disability is assessed pre-intervention (Day 0)Cervical pain-related disability will be assessed with the validated Spanish version of Neck Disability Index. The Neck Disability Index is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash. There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading). The questionnaire is self and administered requires only 5-10 minutes to complete. It is scored from 0 (no disability) to 50 (maximum disability). Each subject select from one of six potential responses for each item ranging from no disability (0) to total disability (5). The ten items are summed to gain the total score.
Posture measured by angle of Kyphosis and angle of lordosis with a computerized device (SpinalMouse® )Posture is assessed pre-intervention (Day 0))SpinalMouse ® is a device that, combined with a computer program, assesses the curvatures of the spine without applying radiation. The device is guided manually on the skin along the spinous process apophysis from C7 to S3. The measuring head follows their contour in the sagittal plane and records clinically relevant data. A software program using an algorithm uses this information to calculate the angle of kyphosis and angle of lordosis. Data obtained have been proved to be reliable and accurate

Other

MeasureTime frameDescription
Garment comfortgarment comfort is assessed at Month 1 when allocated to the garment group intervention.Garment comfort is evaluated with a 5-point Likert scale with the following anchors • 1 - Very dissatisfied • 2 - dissatisfied • 3 - unsure • 4 - satisfied • 5 - Very satisfied
Assessment of global perceived effect of treatmentPerceived effect of treatment is assessed at Month 3 of follow-up.Assessment of global perceived effect of treatment is performed with a Visual Analog Scale . Visual analogue scale is a psychometric measuring instrument designed to document perceived effect of the treatment in individual subjects. A 100-mm long horizontal line with verbal descriptors is used to grade the perceived effect that a patient feels from no improvement (left 0 mm) to an great improvement (right 100 mm).

Countries

Andorra

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026